Effects of Daprodustat on Hemoglobin and Quality of life in patients with non-dialysis chronic kidney disease

In a comprehensive investigation, experts examined the impact of Daprodustat on hemoglobin (Hb) levels and fatigue experienced by patients with anemia related to chronic kidney disease (CKD). The study revealed compelling results, demonstrating a noteworthy rise in hemoglobin levels and a concurrent improvement in fatigue among participants with CKD stages 3-5. Importantly, these positive outcomes were achieved without an escalation in the overall frequency of adverse events. These findings underscore the potential benefits of Daprodustat as a therapeutic option for managing anemia and its associated symptoms in individuals with CKD.

Read the full text article:

https://mu.connect2clinic.com/doctor/description/med-of-the-day/8006b292-a044-41f7-9575-7ace2c82f969